Literature DB >> 15944158

Extracellular trafficking of myocilin in human trabecular meshwork cells.

Katharine M Hardy1, Emely A Hoffman, Pedro Gonzalez, Brian S McKay, W Daniel Stamer.   

Abstract

Myocilin (MYOC) is a protein with a broad expression pattern, but unknown function. MYOC associates with intracellular structures that are consistent with secretory vesicles, however, in most cell types studied, MYOC is limited to the intracellular compartment. In the trabecular meshwork, MYOC associates with intracellular vesicles, but is also found in the extracellular space. The purpose of the present study was to better understand the mechanism of extracellular transport of MYOC in trabecular meshwork cells. Using a biochemical approach, we found that MYOC localizes intracellularly to both the cytosolic and particulate fractions. When intracellular membranes were separated over a linear sucrose gradient, MYOC equilibrated in a fraction less dense than traditional secretory vesicles and lysosomes. In pulse-labeling experiments that followed nascent MYOC over time, the characteristic doublet observed for MYOC by SDS-PAGE did not change, even in the presence of brefeldin A; indicating that MYOC is not glycosylated and is not released via a traditional secretory mechanism. When conditioned media from human trabecular meshwork cells were examined, both native and recombinant MYOC associated with an extracellular membrane population having biochemical characteristics of exosomes, and containing the major histocompatibility complex class II antigen, HLA-DR. The association of MYOC with exosome-like membranes appeared to be specific, on the extracellular face, and reversible. Taken together, data suggest that MYOC appears in the extracellular space of trabecular meshwork cells by an unconventional mechanism, likely associated with exosome-like vesicles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944158     DOI: 10.1074/jbc.M504803200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Trifunctional High-Throughput Screen Identifies Promising Scaffold To Inhibit Grp94 and Treat Myocilin-Associated Glaucoma.

Authors:  Dustin J E Huard; Vincent M Crowley; Yuhong Du; Ricardo A Cordova; Zheying Sun; Moya O Tomlin; Chad A Dickey; John Koren; Laura Blair; Haian Fu; Brian S J Blagg; Raquel L Lieberman
Journal:  ACS Chem Biol       Date:  2018-02-20       Impact factor: 5.100

Review 2.  Glaucoma-associated myocilin: a better understanding but much more to learn.

Authors:  Zachary T Resch; Michael P Fautsch
Journal:  Exp Eye Res       Date:  2008-08-29       Impact factor: 3.467

3.  Myocilin interacts with syntrophins and is member of dystrophin-associated protein complex.

Authors:  Myung Kuk Joe; Changwon Kee; Stanislav I Tomarev
Journal:  J Biol Chem       Date:  2012-02-25       Impact factor: 5.157

4.  Glucose-regulated protein 94 triage of mutant myocilin through endoplasmic reticulum-associated degradation subverts a more efficient autophagic clearance mechanism.

Authors:  Amirthaa Suntharalingam; Jose F Abisambra; John C O'Leary; John Koren; Bo Zhang; Myung Kuk Joe; Laura J Blair; Shannon E Hill; Umesh K Jinwal; Matthew Cockman; Adam S Duerfeldt; Stanislav Tomarev; Brian S J Blagg; Raquel L Lieberman; Chad A Dickey
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

Review 5.  Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine.

Authors:  M Elizabeth Fini; Stephen G Schwartz; Xiaoyi Gao; Shinwu Jeong; Nitin Patel; Tatsuo Itakura; Marianne O Price; Francis W Price; Rohit Varma; W Daniel Stamer
Journal:  Prog Retin Eye Res       Date:  2016-09-22       Impact factor: 21.198

6.  Regulation of myocilin-associated exosome release from human trabecular meshwork cells.

Authors:  Emely A Hoffman; Kristin M Perkumas; Lindsey M Highstrom; W Daniel Stamer
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-24       Impact factor: 4.799

7.  Rho GTPase and cAMP/protein kinase A signaling mediates myocilin-induced alterations in cultured human trabecular meshwork cells.

Authors:  Xiang Shen; Takahisa Koga; Bum-Chan Park; Nirmala SundarRaj; Beatrice Y J T Yue
Journal:  J Biol Chem       Date:  2007-11-05       Impact factor: 5.157

8.  Identification of a novel mutation in the NTF4 gene that causes primary open-angle glaucoma in a Chinese population.

Authors:  Eranga N Vithana; Monisha E Nongpiur; Divya Venkataraman; Stephanie H Chan; Jagadeesh Mavinahalli; Tin Aung
Journal:  Mol Vis       Date:  2010-08-15       Impact factor: 2.367

9.  Clinical features associated with an Asp380His Myocilin mutation in a US family with primary open-angle glaucoma.

Authors:  Mary K Wirtz; John R Samples; Dongseok Choi; N Donna Gaudette
Journal:  Am J Ophthalmol       Date:  2007-05-11       Impact factor: 5.258

10.  Protein expression in human trabecular meshwork: downregulation of RhoGDI by dexamethasone in vitro.

Authors:  Minbin Yu; Jing Sun; Wei Peng; Ziyan Chen; Xianchai Lin; Xuyang Liu; Mingtao Li; Kaili Wu
Journal:  Mol Vis       Date:  2010-02-13       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.